Patient-reported outcomes data from REVEAL at the time of enrollment (baseline): A prospective observational study of patients with polycythemia vera in the United States [PDF]
, 2018 Boccia, Ralph V +7 more
core +2 more sources
JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population. [PDF]
Asian Pac J Cancer Prev, 2019 Syeed N.
europepmc +1 more source
Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21 [PDF]
, 2001 J. Smrcek +4 more
openalex +1 more source
Studies on platelet functions in myeloproliferative disorders
, 1977 Hiroyuki Nozaki
openalex +2 more sources
Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis [PDF]
, 1992 Jun Miyauchi +4 more
openalex +1 more source
Pairing JAK with MEK for improved therapeutic efficiency in myeloproliferative disorders. [PDF]
J Clin Invest, 2019 Williams DA.
europepmc +1 more source
A case of myeloproliferative disorder with t(5;10)(q33;q21.2)
, 2011 VAS De Melo, Reid Ag
openalex +2 more sources
Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia [PDF]
, 2010 Rika Kanezaki +19 more
openalex +1 more source
Constitutive MAP Kinase Activation in Hematopoietic Stem Cells Induces a Myeloproliferative Disorder
, 2011 Eva Chung, Chia-Lin Hsu, Motonari Kondo
openalex +2 more sources
The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018 [PDF]
, 2019 Jan Michiels, Hendrik De Raeve
openalex +1 more source